MDT · News · 20260923N
Guidance / Outlook
Medtronic plc · 2026-09-23 · Importance 74 · Surprise 68 · No source text
Medtronic raised its fiscal 2027 full-year organic revenue growth guidance to 7.25%–7.75%. The increase followed Q1 FY27 results that produced approximately 7% organic revenue growth. The company also raised full-year EPS guidance, although the digest does not provide the revised EPS range.
Key facts
- Medtronic raised full-year guidance to 7.25–7.75%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | +6.4% | Medtronic raised full-year guidance to 7.25–7.75%. |